Docetaxel trials for Metastatic Prostate Cancer

All Docetaxel trials · All Metastatic Prostate Cancer trials

Phase breakdown

Recruiting trials studying Docetaxel for Metastatic Prostate Cancer

• Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
  NCT05983783 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: Male · 1 location
• Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
  NCT07590934 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 37 locations
• Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
  NCT06439225 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 14 locations

Common questions

How many trials study Docetaxel for Metastatic Prostate Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.